The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease
Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data
Objective: This study evaluates whether clinical, biological, and neuroimaging baseline markers can predict the onset of significant cognitive-based milestones developed in these cohorts over a…Assessing the Impact of Deep Brain Stimulation on Cognitive Impairment in Parkinson’s Disease: a longitudinal study.
Objective: To longitudinally assess cognitive function post-DBS in Patients with Parkinson's Disease. Background: Parkinson's disease (PD) is a chronic neurodegenerative condition that primarily affects the…The role of cognitive functions on the outcomes of an intensive multidisciplinary rehabilitation program for people with Parkinson’s disease
Objective: This study examined relationships among cognitive functions and rehabilitation outcomes in patients with Parkinson's disease (PD) during a 4-week intensive, multidisciplinary rehabilitation program (Vicenza,…Early GBA-Related Parkinson’s Disease has a Distinct Clinical Phenotype and Cholinergic Innervation
Objective: This study aims to characterize the clinical features and cholinergic innervation of early Parkinson’s disease (PD) patients with GBA mutations (GBA-PD). Background: The GBA-PD…Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report
Objective: The aim of this research was to develop and verify the effects of a Non-Invasive Neuromodulation protocol associated with Neurofunctional Physiotherapy on motor functions,…New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia
Objective: Biomarker development for Parkinson’s disease and related dementia. Background: α-Synuclein (α-syn) strains can serve as discriminators of Parkinson's disease (PD) from other α-synucleinopathies. However,…Cognitive function of patients with Parkinson´s Disease after Deep Brain Stimulation: a gene- and variant-based approach
Objective: To investigate the cognitive outcomes of Deep Brain Stimulation (DBS) in conjunction with the genetic profile of Parkinson´s disease (PD) patients. Background: There are…Orthostatic Hypotension is Associated with Worse Verbal Letter Fluency and Lower Neural Efficiency While Upright in Parkinson’s Disease: A Pilot Study
Objective: To evaluate positional effects on cognitive performance and cerebral hemodynamics in Parkinson’s disease (PD) patients with and without orthostatic hypotension (OH). Background: OH is…Investigating Cognitive Impairments in early Parkinson’s disease
Objective: We investigated cognitive performance in patients with early Parkinson’s disease (PD). Background: Cognitive impairment is a common non-motor symptom of PD, generally detected later…
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 128
- Next Page »